🇺🇸 FDA
Patent

US 8710231

Inhibitor of casein kinase 1delta and casein kinase 1E

granted A61KA61K31/4439A61P

Quick answer

US patent 8710231 (Inhibitor of casein kinase 1delta and casein kinase 1E) held by Pharmadesign, Inc. expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmadesign, Inc.
Grant date
Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/4439, A61P, A61P25/00, A61P25/16